(13-177) The Risk of Treatment Failure in Cefdinir in Susceptible Gram-Negative Bacteremia

Wednesday, December 10, 2025

3:15 PM - 4:15 PM

Location: Bayside A, Level 1

Residency Program: HCA Houston Healthcare Clear Lake
Residency Program Type: PGY1 (Pharmacy)
Residency Program Location: Texas

Co-Author(s): Nithin Yenugu, Noopur Shah, Taylor Schieber

Primary Author(s)